Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5904469 | 0.78 | TNKS2 (0.36) | GAA | |
| SCHEMBL5531635 | 0.77 | TNKS2 (0.36) | MAPT | |
| SCHEMBL20067379 | 0.73 | PBRM1 (0.31) | GAA | |
| SCHEMBL20067380 | 0.73 | BRD4 (0.31) | — | |
| SCHEMBL16772246 | 0.72 | GAA (0.31) | GAAMAPT | |
| SCHEMBL12143219 | 0.72 | GAA (0.39) | GAAMAPT | |
| SCHEMBL460544 | 0.71 | GAA (0.36) | GAAMAPT | |
| SCHEMBL11458282 | 0.71 | PARP1 (0.36) | — | |
| SCHEMBL869745 | 0.70 | — | — | |
| SCHEMBL12096478 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1472230-B1 | ANSAMYCINS HAVING IMPROVED PHARMACOLOGICAL AND BIOLOGICAL PROPERTIES | CONFORMA THERAPEUTICS CORP (US) | 2009-06-17 | — | — | EP | claimed |
| US-20250268015-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2025-08-21 | — | — | US | disclosed |
| CN-109988144-B | Aromatic vinyl or aromatic ethyl derivative, preparation method, intermediate, pharmaceutical composition and application thereof | 广州再极医药科技有限公司 | 2024-07-05 | — | — | CN | disclosed |
| EP-4265624-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | Lg Chem, Ltd. (KR) | 2023-10-25 | — | — | EP | disclosed |
| US-20230320214-A1 | ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANIC COMPOUND | LG CHEM, LTD. (KR) | 2023-10-05 | — | — | US | disclosed |
| EP-4194460-A1 | ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANIC COMPOUND | Lg Chem, Ltd. (KR) | 2023-06-14 | — | — | EP | disclosed |
| CN-115989725-A | Compound and organic light emitting device including the same | 株式会社LG化学 | 2023-04-18 | — | — | CN | disclosed |
| CN-115968592-A | Organic light emitting device comprising organic compound | 株式会社LG化学 | 2023-04-14 | — | — | CN | disclosed |
| WO-2022139525-A1 | ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANIC COMPOUND | 주식회사 엘지화학 | 2022-06-30 | — | — | WO | disclosed |
| WO-2022139513-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2022-06-30 | — | — | WO | disclosed |
| US-20180105534-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE | NANJING TOPTO MATERIALS CO.,LTD. (CN) | 2018-04-19 | — | — | US | disclosed |
| US-20180105534-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE | NANJING TOPTO MATERIALS CO.,LTD. (CN) | 2018-04-19 | — | — | US | disclosed |
| WO-2009004146-A2 | NOVEL HERBIMYCIN A ANALOGUE DERIVATIVES, COMPOSITIONS CONTAINING SAME AND USE THEREOF | SANOFI-AVENTIS (FR) | 2009-01-08 | — | — | WO | disclosed |
| EP-1406620-B1 | VINYL PHENYL DERIVATIVES AS GLK ACTIVATORS | ASTRAZENECA AB (SE) | 2006-11-02 | — | — | EP | disclosed |
| WO-1999051223-A1 | BENZOQUINOID ANSAMYCINS FOR THE TREATMENT OF CARDIAC ARREST AND STROKE | UNIVERSITY OF PITTSBURGH OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 1999-10-14 | — | — | WO | disclosed |
| US-3886165-A | Indolylimidoylheterocyclics | MEAD JOHNSON & CO | 1975-05-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180105534-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE | PNMT, H1-0, H1-10 | GAA 2709/4885MAPT 3451/4885 |
| US-20230320214-A1 | ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANIC COMPOUND | CYP1A1, AOX1, CYP1B1 | GAA 2399/4885MAPT 1319/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.